MS Society launches public appeal for £100m funding
The Stop MS Appeal aims to raise the funds over ten years to find treatments for everyone living with the progressive, immune-mediated disorder.
Read More
Tag: appeal
NHS could claw back £502m if Lyrica ruling upheld, study finds
The NHS could reclaim up to £502 million in excess prescribing costs relating to Pfizer’s pregabalin if the drug giant’s last effort to uphold the drug’s legal protection is unsuccessful, a study has found.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
